1. Home
  2. AIMD vs KRKR Comparison

AIMD vs KRKR Comparison

Compare AIMD & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • KRKR
  • Stock Information
  • Founded
  • AIMD 1984
  • KRKR 2010
  • Country
  • AIMD United States
  • KRKR China
  • Employees
  • AIMD N/A
  • KRKR N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • AIMD Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • AIMD 6.0M
  • KRKR 6.6M
  • IPO Year
  • AIMD N/A
  • KRKR 2019
  • Fundamental
  • Price
  • AIMD $0.46
  • KRKR $3.38
  • Analyst Decision
  • AIMD
  • KRKR
  • Analyst Count
  • AIMD 0
  • KRKR 0
  • Target Price
  • AIMD N/A
  • KRKR N/A
  • AVG Volume (30 Days)
  • AIMD 132.1K
  • KRKR 22.4K
  • Earning Date
  • AIMD 11-06-2024
  • KRKR 12-31-2024
  • Dividend Yield
  • AIMD N/A
  • KRKR N/A
  • EPS Growth
  • AIMD N/A
  • KRKR N/A
  • EPS
  • AIMD N/A
  • KRKR N/A
  • Revenue
  • AIMD $40,633.00
  • KRKR $41,654,350.00
  • Revenue This Year
  • AIMD N/A
  • KRKR $45.99
  • Revenue Next Year
  • AIMD N/A
  • KRKR $31.46
  • P/E Ratio
  • AIMD N/A
  • KRKR N/A
  • Revenue Growth
  • AIMD N/A
  • KRKR N/A
  • 52 Week Low
  • AIMD $0.40
  • KRKR $2.76
  • 52 Week High
  • AIMD $4.29
  • KRKR $12.60
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 49.75
  • KRKR 44.02
  • Support Level
  • AIMD $0.42
  • KRKR $3.10
  • Resistance Level
  • AIMD $0.48
  • KRKR $3.69
  • Average True Range (ATR)
  • AIMD 0.04
  • KRKR 0.35
  • MACD
  • AIMD 0.00
  • KRKR 0.03
  • Stochastic Oscillator
  • AIMD 36.48
  • KRKR 41.74

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: